background
multipl
sclerosi
ms
character
central
nervou
system
inflamm
demyelin
increas
evid
demonstr
signific
neuron
damag
also
occur
associ
perman
function
impair
current
ms
therapi
limit
abil
prevent
neuron
damag
suggest
addit
neuroprotect
therapi
need
compound
activ
nad
depend
deacetylas
prevent
neuron
loss
autoimmunemedi
ms
model
mechan
effect
unknown
unclear
whether
activ
compound
exert
similar
effect
demyelin
diseas
induc
etiolog
measur
neuron
loss
mice
inocul
neurotrop
strain
mous
hepat
viru
induc
mslike
diseas
result
oral
treatment
activ
compound
significantli
increas
activ
within
optic
nerv
prevent
neuron
loss
optic
neuriti
inflammatori
demyelin
optic
nerv
lesion
occur
ms
anim
model
induc
neuron
loss
associ
reactiv
oxygen
speci
ro
accumul
treatment
significantli
reduc
ro
level
promot
increas
express
enzym
involv
mitochondri
function
reduct
ro
exert
similar
protect
effect
eae
spinal
cord
decreas
demyelin
conclus
result
demonstr
activ
compound
prevent
neuron
loss
viralinduc
demyelin
diseas
similar
effect
autoimmunemedi
diseas
one
mechan
neuroprotect
effect
involv
increas
mitochondri
biogenesi
reduct
oxid
stress
activ
repres
potenti
neuroprotect
therapi
ms
understand
common
mechan
effect
distinct
diseas
model
help
identifi
target
specif
therapi
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
signific
neuron
damag
also
occur
ms
correl
perman
neurolog
dysfunct
current
therapi
reduc
inflammatori
compon
ms
abil
prevent
neuron
damag
limit
suggest
addit
therapi
neuroprotect
benefit
need
evid
suggest
ms
autoimmun
diseas
cn
myelin
exact
etiolog
known
evid
suggest
genet
viralmedi
trigger
etiolog
unknown
sever
ms
anim
model
use
common
ms
model
experiment
autoimmun
encephalomyel
eae
autoimmun
driven
cn
demyelin
diseas
also
exhibit
neuron
damag
anoth
ms
model
induc
infect
neurotrop
strain
mous
hepat
viru
mhv
induc
cn
inflamm
demyelin
similar
eae
etiolog
distinct
involv
direct
neuron
infect
demyelin
depend
intact
immun
system
therefor
model
provid
uniqu
contrast
system
studi
potenti
neuroprotect
strategi
ms
optic
nerv
frequent
site
ms
lesion
optic
neuriti
common
present
sign
ms
similarli
optic
neuriti
occur
high
frequenc
eae
mhv
model
ms
addit
optic
nerv
inflamm
studi
demonstr
signific
axon
damag
loss
retin
ganglion
cell
rgc
neuron
compris
optic
nerv
also
found
eae
optic
neuriti
examin
mhv
model
rgc
readili
quantifi
allow
optic
neuriti
serv
repres
lesion
assess
neuron
damag
activ
naddepend
deacetylas
involv
cell
stress
respons
attenu
neuron
damag
eae
although
mechan
mediat
effect
known
reduc
oxid
stress
promot
mitochondri
biogenesi
muscl
cultur
neuron
cell
oxid
stress
play
role
neuron
degener
ms
eae
suggest
activ
may
prevent
neuron
damag
increas
mitochondri
function
reduc
oxid
stress
mechan
neuron
damag
demyelin
diseas
fulli
understood
oxid
stress
common
mechan
cellular
injuri
like
occur
infect
current
studi
character
mechan
neuron
loss
viralinduc
demyelin
diseas
examin
abil
activ
compound
prevent
neuron
loss
reduc
oxid
stress
regul
protein
promot
mitochondri
function
fourweekold
femal
mice
purchas
jackson
laboratori
bar
harbor
treatment
anim
review
approv
institut
anim
care
use
committe
univers
pennsylvania
mice
maintain
fed
ad
libitum
approv
anim
care
facil
mhvfree
mice
inocul
intracrani
half
lethal
dose
demyelin
strain
plaqu
form
unit
pfu
relat
nondemyelin
strain
pfu
use
neg
control
isogen
recombin
strain
contain
fluoresc
tag
pfu
use
posit
control
pfu
neg
control
due
differ
replic
elimin
dose
result
equival
viral
load
cn
inocul
strain
perform
describ
previous
mice
monitor
daili
mortal
sign
diseas
mockinfect
control
inocul
similarli
uninfect
cell
lysat
compar
dilut
sirtri
gsk
compani
cambridg
prepar
pb
contain
methyl
cellulos
tween
mice
treat
mgkgmouseday
oral
gavag
dose
chosen
base
previous
measur
pharmacokinet
drug
abil
activ
use
previous
maxim
effect
seven
day
day
treatment
group
receiv
start
day
sacrific
evalu
whether
target
activ
one
group
mice
receiv
inhibitor
mgkgday
ip
day
highest
inhibitori
activ
compar
analogu
previou
studi
shown
treatment
alon
result
acetyl
target
previous
shown
inhibitor
condit
delet
gene
exacerb
rgc
loss
optic
nerv
diseas
model
rgc
label
count
describ
previous
briefli
hydroxystilbamidin
fluorogold
molecular
probe
eugen
steril
water
inject
stereotact
superior
colliculu
hole
drill
skull
mice
kill
day
infect
eye
remov
fix
paraformaldehyd
retina
isol
prepar
flatten
wholemount
view
fluoresc
microscop
eclips
nikon
tokyo
japan
photograph
magnif
standard
field
retin
radiu
center
retina
quadrant
rgc
number
shown
experi
repres
total
number
rgc
count
per
eye
rgc
count
mask
investig
use
imag
analysi
softwar
imagepro
plu
media
cybernet
silver
spring
md
altern
confirm
rgc
number
rgc
immunolabel
antibodi
retina
dissect
flat
previous
report
retina
wash
pb
permeabil
tritonx
pb
freez
min
rins
pb
contain
triton
incub
overnight
antibodi
santa
cruz
dilut
block
buffer
pb
bovin
serum
albumin
triton
x
retina
wash
three
time
pb
incub
hour
room
temperatur
rt
antigoat
secondari
antibodi
dilut
block
buffer
wash
pb
mount
vitreou
side
slide
antifad
solut
cell
count
field
describ
fluorogold
label
rgc
mice
kill
day
post
inocul
pi
perfus
transcardi
pb
follow
pb
contain
paraformaldehyd
pfa
spinal
cord
optic
nerv
collect
postfix
pfa
overnight
embed
paraffin
spinal
cord
tissu
section
stain
either
luxol
fast
blue
lfb
detect
demyelin
antineurofila
antibodi
detect
loss
axon
area
demyelin
lfb
stain
quantifi
use
point
scale
describ
earlier
demyelin
rare
foci
demyelin
foci
demyelin
confluent
area
demyelin
two
three
section
examin
three
spinal
cord
level
cervic
thorac
lumbar
mous
neurofila
stain
done
accord
previous
publish
protocol
briefli
paraffin
embed
section
dewax
rehydr
permeabil
pb
section
block
block
reagent
vectastain
elit
abc
kit
incub
rabbit
antineurofila
antibodi
abcam
overnight
wash
incub
goat
biotinyl
antirabbit
secondari
antibodi
invitrogen
hour
rt
abc
detect
perform
use
vectastain
elit
abc
kit
dab
diaminobenzidin
substrat
kit
vector
laboratori
burlingam
ca
accord
manufactur
instruct
character
viru
induc
inflamm
spinal
cord
day
pi
mice
stain
h
e
describ
previous
score
use
inflamm
scale
inflamm
inflammatori
cell
inflammatori
cell
local
near
white
matter
small
patch
inflammatori
cell
larg
inflammatori
plaqu
diffus
inflamm
experi
repeat
three
time
mice
group
slide
code
read
blind
manner
day
pi
spinal
cord
section
also
stain
macrophagemicrogli
marker
wako
japan
describ
previous
stain
section
counterstain
hematoxylin
vector
laboratori
optic
nerv
tissu
section
longitudin
section
stain
h
e
lfb
antineurofila
antibodi
use
method
describ
activ
determin
fluorometr
kit
biomol
plymouth
meet
pa
perform
accord
manufactur
instruct
optic
nerv
homogen
assay
buffer
incub
min
allow
degrad
contamin
nad
protein
concentr
determin
use
bca
protein
assay
kit
thermo
scientif
rockford
il
homogen
proteinwel
incub
fluor
de
substrat
enzo
life
scienc
presenc
absenc
nad
determin
nad
depend
activ
reaction
termin
ad
fluor
de
ly
develop
enzo
life
scienc
mm
nicotinamid
min
incub
fluoresc
valu
read
fluorometr
plate
reader
wallac
victor
multi
label
counter
perkin
elmer
waltham
excit
wavelength
nm
emiss
wavelength
nm
inhibitor
nicotinamid
mm
suramin
sirtinol
use
confirm
specif
reaction
mitosox
red
invitrogen
superoxid
indic
fluorogen
dye
select
detect
superoxid
reactiv
oxygen
speci
ro
mitochondria
mitosox
red
reagent
cell
permeabl
select
target
mitochondria
oxid
superoxid
exhibit
red
fluoresc
mitosox
stain
done
accord
previous
publish
protocol
briefli
mitosox
reagent
dilut
final
concentr
pb
optic
nerv
incub
min
incub
nerv
wash
three
time
pb
fix
paraformaldehyd
min
mount
optim
cut
temperatur
oct
compound
ted
pella
inc
red
ca
crosssect
made
mount
onto
glass
slide
mowiol
mount
medium
observ
eclips
nikon
fluoresc
microscop
use
excit
nmemiss
nm
photograph
magnif
photograph
taken
center
within
optic
nerv
cross
section
blind
investig
use
standard
exposur
stain
quantifi
calcul
optic
densiti
use
imag
j
softwar
nihgov
optic
nerv
retina
ripa
buffer
mm
nacl
desoxychol
acid
sd
mm
tri
ph
ultrason
ice
time
sec
interv
obtain
total
protein
extract
cell
lysat
centrifug
g
min
protein
concentr
supernat
determin
use
bca
protein
assay
kit
thermo
scientif
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
perform
polyacrylamid
gel
protein
per
lane
transfer
nitrocellulos
high
bound
ecl
membran
ge
healthcar
bioscienc
pittsburgh
pa
membran
block
odyssey
block
buffer
licor
biotechnolog
lincoln
ne
hr
rt
probe
rabbit
polyclon
antibodi
abcam
cambridg
genetex
irvin
ca
novu
biolog
littleton
co
mous
monoclon
antibodi
succin
dehydrogenas
b
sdhb
abcam
overnight
wash
three
time
use
pb
membran
incub
goat
antirabbit
igg
goat
antimous
igg
licor
secondari
antibodi
dilut
hr
rt
wash
three
time
pb
fluoresc
visual
use
odyssey
infrar
imag
system
licor
normal
signal
blot
membran
stain
sigma
intens
band
determin
use
imag
j
softwar
nihgov
data
express
mean
sem
differ
rgc
number
activ
protein
express
assess
use
oneway
anova
follow
student
neumankeul
posthoc
test
statist
differ
consid
signific
p
optic
nerv
infect
mice
develop
inflamm
peak
day
inocul
follow
signific
demyelin
day
wherea
infect
mice
almost
inflamm
demyelin
found
similar
result
optic
nerv
stain
h
e
lfb
current
studi
data
shown
examin
whether
infect
demyelin
strain
mhv
also
result
neuron
loss
rgc
label
fourweekold
virusfre
mice
one
week
later
mice
inocul
mice
sacrif
day
postinfect
rgc
count
signific
differ
found
total
rgc
number
count
standard
retin
field
within
one
region
retina
infect
mice
significantli
fewer
surviv
rgc
compar
noninfect
mice
figur
mice
infect
nondemyelin
control
strain
show
rgc
loss
compar
noninfect
control
consist
rgc
loss
induc
recombin
strain
isogen
except
egfp
fluoresc
marker
similar
demyelin
properti
abil
induc
optic
neuriti
also
induc
signific
rgc
loss
compar
noninfect
control
infect
mice
figur
activ
compound
promot
deacetylas
activ
vitro
vivo
activ
prevent
rgc
loss
eae
optic
neuriti
specif
increas
activ
optic
nerv
assess
determin
time
activ
chang
optic
nerv
wildtyp
mice
treat
activ
oral
gavag
dose
mgkgday
day
mice
kill
day
differ
time
interv
final
dose
optic
nerv
isol
activ
determin
fluorometr
substrat
assay
kit
result
show
signific
increas
activ
hr
treatment
figur
increas
activ
transient
declin
back
control
level
hr
next
examin
activ
optic
nerv
infect
mice
day
treatment
week
old
mice
infect
treat
start
day
mgkgday
day
day
mice
sacrif
hr
treatment
protein
extract
optic
nerv
activ
assay
optic
nerv
mice
treat
show
signific
increas
activ
compar
control
untreat
infect
mice
figur
interestingli
untreat
infect
mous
optic
nerv
also
show
smaller
signific
increas
compar
control
possibl
natur
defens
mechan
also
examin
level
retina
optic
nerv
mice
day
without
treatment
protein
express
level
measur
western
blot
show
signific
differ
treatment
group
day
optic
nerv
figur
similar
lack
chang
day
optic
nerv
retina
either
time
point
data
shown
shown
activ
attenu
rgc
loss
eae
optic
neuriti
howev
neuron
damag
mhv
model
ms
occur
differ
mechan
eae
includ
direct
viral
infect
neuron
macrophagemedi
myelin
strip
axon
abil
attenu
neuron
loss
infect
mice
therefor
examin
rgc
week
old
mice
label
fluorogold
mice
inocul
one
week
later
treatment
group
administ
mgkgday
oral
gavag
start
day
day
decreas
rgc
number
untreat
mice
compar
control
significantli
attenu
treatment
figur
confirm
neuroprotect
effect
week
old
mice
inocul
recombin
strain
mhv
treatment
group
administ
dose
day
without
inhibitor
mgkg
day
ip
day
rgc
label
stain
count
consist
result
figur
induc
signific
decreas
rgc
treatment
attenu
rgc
loss
treatment
group
receiv
show
signific
decreas
rgc
number
compar
group
receiv
figur
c
demonstr
rgc
protect
effect
depend
treatment
inhibitor
alon
reduc
rgc
surviv
data
shown
similar
prior
studi
examin
whether
viral
induc
also
lead
axon
loss
optic
nerv
stain
antineurofila
optic
nerv
isol
activ
determin
fluorometr
substrat
assay
kit
activ
significantli
increas
p
hr
treatment
increas
activ
transient
return
control
level
hr
b
activ
optic
nerv
infect
mice
day
mgkgday
treatment
n
show
signific
increas
activ
compar
noninfect
control
n
p
untreat
infect
p
mice
n
c
express
level
protein
optic
nerv
mice
day
without
treatment
show
signific
chang
n
antibodi
area
axon
stain
quantifi
describ
previous
thirti
day
post
inocul
nerv
mice
show
significantli
decreas
axon
stain
compar
control
nerv
nerv
mice
figur
f
treatment
show
signific
preserv
axon
wherea
treat
mice
receiv
cotreat
show
chang
compar
infect
group
figur
e
f
mitosox
red
detect
superoxid
within
mitochondria
use
determin
whether
ro
accumul
induc
optic
neuriti
mice
infect
sacrif
day
postinocul
optic
nerv
inflamm
known
peak
optic
nerv
isol
stain
mitosox
red
reveal
increas
superoxid
anion
infect
optic
nerv
compar
control
optic
nerv
optic
nerv
infect
mice
treat
daili
mgkg
significantli
less
stain
untreat
infect
mice
figur
b
examin
accumul
superoxid
optic
nerv
day
postinocul
without
daili
treatment
mgkg
result
show
signific
increas
mitosox
red
stain
optic
nerv
mice
infect
compar
control
optic
nerv
treatment
day
significantli
attenu
accumul
superoxid
stain
figur
infect
significantli
decreas
rgc
number
compar
noninfect
control
mice
n
p
treatment
mgkgday
day
n
result
signific
p
attenu
rgc
loss
b
mice
inocul
recombin
strain
mhv
treatment
group
administ
mgkgday
day
without
inhibitor
mgkgday
ip
day
rgc
label
stain
count
n
induc
signific
decreas
rgc
p
compar
control
n
infect
n
mice
treatment
n
significantli
p
attenu
rgc
loss
treatment
group
receiv
n
show
signific
decreas
p
rgc
number
compar
group
receiv
demonstr
rgc
protect
effect
depend
label
rgc
repres
retin
field
c
control
infect
e
infect
f
infect
treatment
g
infect
treatment
fewer
rgc
seen
correspond
area
retina
infect
mous
retina
infect
mous
treat
mgkgday
day
show
numer
rgc
similar
noninfect
control
wherea
infect
mous
treat
day
show
fewer
rgc
scale
bar
cg
optic
nerv
retina
isol
peak
inflamm
day
postinocul
mice
treat
without
mgkg
daili
express
level
mitochondri
antioxid
marker
measur
sdh
key
mitochondri
enzym
catalys
oxid
succin
fumar
kreb
cycl
feed
electron
respiratori
chain
ubiquinon
uq
pool
sdh
function
mitochondri
energi
gener
also
role
oxygen
sens
protein
level
sdhb
show
signific
decreas
infect
group
compar
control
treatment
seven
day
show
signific
increas
sdhb
protein
express
compar
untreat
infect
mice
optic
nerv
retina
figur
b
also
measur
protein
express
mitochondri
protein
bind
superoxid
byproduct
oxid
phosphoryl
convert
hydrogen
peroxid
diatom
oxygen
result
show
signific
decreas
express
optic
nerv
retina
infect
mice
treatment
significantli
attenu
chang
figur
c
e
peroxisom
prolifer
activ
receptor
ppar
coactiv
transcript
coactiv
identifi
upstream
regul
mitochondri
number
function
activ
deacetyl
result
show
signific
decreas
express
infect
treatment
significantli
increas
protein
level
retina
day
treat
mice
figur
f
level
optic
nerv
low
detect
addit
optic
nerv
spread
spinal
cord
induc
signific
demyelin
axon
injuri
intracrani
inocul
therefor
use
spinal
cord
confirm
neuroprotect
effect
infect
mice
sinc
tissu
limit
optic
nerv
histolog
studi
also
perform
use
spinal
cord
larger
area
white
matter
assess
effect
demyelin
spinal
cord
isol
mice
infect
day
treat
without
mgkg
daili
demyelin
level
measur
use
lfb
stain
patholog
assess
five
seven
crosssect
spinal
cord
cervic
thorac
lumbar
region
demyelin
plaqu
quantifi
scale
four
quadrant
two
spinal
cord
level
mous
spinal
cord
section
infect
group
show
signific
increas
demyelin
score
compar
control
infect
group
figur
b
f
group
receiv
show
signific
decreas
demyelin
score
compar
infect
group
figur
f
h
contrast
treat
mice
also
receiv
figur
effect
neuron
loss
optic
nerv
neurofila
stain
optic
nerv
repres
control
b
infect
c
infect
infect
treatment
e
infect
treatment
demonstr
normal
axon
stain
b
area
axon
loss
c
e
scale
bar
ae
f
neurofila
stain
optic
nerv
day
postinocul
demonstr
signific
loss
p
axon
mice
infect
n
compar
normal
axon
stain
control
n
n
mice
treatment
n
show
signific
preserv
p
axon
compar
infect
mice
treatment
group
cotreat
n
show
signific
reduct
p
axon
stain
compar
treatment
group
infect
lane
infect
lane
mice
averag
level
sdhb
measur
western
blot
n
show
signific
p
decreas
protein
extract
optic
nerv
b
retina
infect
mice
day
postinocul
compar
control
mice
infect
mice
treat
mgkgday
show
signific
increas
p
sdhb
protein
express
compar
untreat
infect
mice
signific
decreas
p
express
n
optic
nerv
c
retina
e
infect
mice
compar
control
mice
treatment
significantli
p
attenu
chang
express
show
signific
p
decreas
retina
f
n
infect
treatment
day
significantli
p
increas
protein
level
see
figur
previou
page
figur
treatment
reduc
ro
infect
optic
nerv
day
infect
mice
infect
sacrif
day
postinocul
optic
nerv
inflamm
known
peak
repres
imag
show
optic
nerv
stain
mitosox
red
increas
stain
superoxid
anion
infect
optic
nerv
compar
control
optic
nerv
less
stain
present
optic
nerv
infect
mous
treat
mgkgday
day
b
quantif
mitosox
red
stain
optic
nerv
averag
optic
densiti
central
area
optic
nerv
determin
imag
j
softwar
treatment
n
significantli
p
attenu
increas
superoxid
anion
stain
induc
n
infect
rel
control
p
c
repres
imag
show
optic
nerv
stain
mitosox
red
day
infect
increas
stain
infect
optic
nerv
compar
control
optic
nerv
less
stain
present
optic
nerv
infect
mous
treat
mgkgday
day
treatment
n
significantli
p
attenu
increas
averag
optic
densiti
superoxid
anion
stain
observ
n
infect
rel
control
n
p
scale
bar
c
inhibitor
show
signific
reduct
demyelin
figur
fj
serial
section
stain
antibodi
neurofila
show
focal
axon
degener
area
demyelin
figur
e
g
k
investig
whether
effect
inflamm
spinal
cord
day
pi
mice
without
treatment
mgkg
daili
cut
coron
section
stain
h
e
score
use
point
scale
describ
previous
signific
increas
inflamm
infect
mice
compar
control
figur
interestingli
signific
differ
observ
inflamm
score
infect
group
infect
mice
treat
figur
signific
effect
inflamm
observ
h
e
stain
section
spinal
cord
mice
day
pi
although
inflamm
level
low
data
shown
investig
effect
inflamm
day
post
infect
section
stain
antibodi
macrophagemicrogli
marker
result
suggest
differ
area
number
microglia
present
although
plaqu
contain
stain
cell
regardless
treatment
figur
result
confirm
infect
demylin
strain
induc
optic
neuriti
model
ms
first
time
demonstr
signific
rgc
loss
occur
model
well
activ
compound
significantli
attenu
neuron
loss
induc
infect
similar
neuroprotect
effect
mediat
sever
activ
previous
demonstr
two
differ
eae
model
ms
relapsingremit
eae
sjlj
mice
chronic
eae
mice
figur
effect
demyelin
spinal
cord
demyelin
score
rel
scale
histolog
evalu
lfb
stain
spinal
cord
n
per
group
taken
day
infect
show
signific
increas
p
infect
group
compar
control
infect
mice
treatment
show
signific
reduct
demyelin
score
p
treatment
group
receiv
show
signific
increas
p
demyelin
score
compar
group
receiv
alon
signific
chang
compar
untreat
infect
mice
lfb
left
neurofila
right
stain
serial
spinal
cord
section
repres
b
c
control
e
infect
f
g
infect
h
infect
treatment
j
k
infect
treatment
mous
neurofila
stain
show
axon
loss
limit
area
demyelin
seen
lfb
stain
section
scale
bar
bk
mechan
effect
assess
beyond
role
activ
current
result
suggest
activ
work
promot
mitochondri
function
reduc
accumul
ro
oxid
stress
demonstr
previous
eae
clear
whether
similar
mechan
would
found
mhv
induc
demyelin
diseas
found
activ
associ
reduc
accumul
ro
optic
nerv
one
limit
studi
address
futur
studi
causal
relat
effect
confirm
use
ro
inhibitor
posit
control
interestingli
pathogenesi
neuron
injuri
begin
differ
trigger
eae
optic
neuriti
compar
mhv
optic
neuriti
despit
similar
gross
level
inflamm
axon
injuri
loss
neuron
relaps
remit
eae
occur
secondari
inflamm
predominantli
mediat
effector
cell
wherea
neurotrop
strain
mhv
directli
infect
neuron
lead
direct
injuri
lead
myelin
strip
activ
microgliamacrophag
mhv
induc
diseas
also
occur
even
absenc
lymphocyt
abil
activ
prevent
neuron
loss
model
therefor
suggest
modul
common
mechan
neurodegener
downstream
initi
mechan
injuri
activ
appear
work
increas
express
protein
involv
mitochondri
biogenesi
reduct
ro
indic
import
target
neuroprotect
therapi
consist
activ
found
similar
neuroprotect
effect
model
traumat
optic
nerv
injuri
resveratrol
naturallyoccur
polyphenol
compound
studi
activ
role
resveratrol
neuroprotect
figur
effect
inflamm
spinal
cord
spinal
cord
section
n
per
group
day
post
infect
infect
group
treat
mgkg
daili
stain
h
e
score
use
rel
inflamm
scale
signific
increas
p
inflamm
score
treat
mice
compar
control
signific
differ
inflamm
score
observ
infect
group
infect
mice
treat
day
postinnocul
limit
inflamm
observ
h
e
stain
spinal
cord
inflamm
occur
consist
almost
exclus
macrophagesmicroglia
thu
section
n
per
group
immunostain
assess
rel
level
inflamm
repres
spinal
cord
section
shown
b
control
c
infect
infect
e
infect
treatment
f
infect
treatment
mice
box
low
magnif
section
left
column
indic
area
shown
high
magnif
right
column
increas
foci
posit
cell
present
infect
mice
without
treatment
compar
control
mice
scale
bar
bf
suggest
neurodegen
process
besid
demyelin
diseas
includ
model
alzheim
diseas
amyotroph
later
sclerosi
axotom
dorsal
root
ganglion
cell
howev
resveratrol
also
modul
varieti
cellular
signal
pathway
independ
abil
activ
exert
number
potenti
benefici
effect
includ
anticarcinogen
properti
antiinflammatori
effect
inhibit
proinflammatori
mediat
andor
activ
immun
cell
inhibit
induc
nitric
oxid
synthas
current
studi
use
activ
avoid
activ
pathway
affect
resveratrol
addit
compound
like
activ
distinct
mechan
resveratrol
exert
similar
activ
level
concentr
order
magnitud
lower
resveratrol
shown
good
safeti
profil
earli
phase
clinic
trial
addit
shown
previous
prevent
oxid
stressinduc
loss
neuron
vitro
specif
target
deacetylas
mediat
observ
chang
express
mitochondri
enzym
requir
studi
origin
identifi
histon
deacetylas
lead
larg
chang
overal
gene
express
also
found
deacetyl
number
protein
target
includ
transcript
factor
may
directli
affect
express
specif
gene
addit
posttransl
modif
mitochondri
enzym
may
promot
mitochondri
biogenesi
deacetyl
shown
muscl
cell
result
show
transient
increas
activ
follow
administr
capabl
provid
longterm
neuroprotect
effect
infect
mice
suggest
deacetyl
substrat
may
persist
beyond
time
acut
activ
current
studi
show
exert
neuroprotect
effect
without
suppress
gross
level
inflamm
assess
h
e
stain
confirm
stain
macrophagemicrogli
marker
unlik
eae
model
ms
mediat
cell
viru
induc
model
ms
inflamm
consist
almost
exclus
macrophag
demonstr
prior
studi
interest
activ
fail
block
migrat
macrophag
cn
prior
studi
shown
activ
block
accumul
macrophag
peripher
tissu
although
even
outsid
cn
effect
appear
tissu
specif
evid
suggest
neurolog
dysfunct
ms
occur
result
axon
degener
may
depend
occur
independ
chronic
demyelin
result
show
activ
preserv
rgc
reduc
axon
loss
follow
infect
mhv
treat
mice
also
receiv
inhibitor
show
signific
reduct
axon
loss
preserv
rgc
suggest
neuroprotect
effect
mediat
activ
furthermor
activ
prevent
myelin
loss
follow
mhv
infect
find
consist
recent
studi
show
mice
overexpress
neuron
reduc
axon
loss
demyelin
eae
model
ms
togeth
result
suggest
promot
neuron
surviv
prevent
demyelin
cn
demyelin
diseas
activ
compound
repres
potenti
new
neuroprotect
agent
demyelin
diseas
result
suggest
activ
modul
oxid
stress
common
mechan
neuron
injuri
begin
identifi
mechan
target
develop
specif
neuroprotect
therapi
compet
interest
provid
cost
sirtri
gsk
compani
kss
studi
fund
provid
sirtri
studi
kss
financi
interest
relationship
sirtri
relat
compound
author
compet
interest
declar
author
contribut
rsk
help
design
studi
perform
experi
analyz
data
prepar
manuscript
kd
assist
induct
mhv
diseas
prepar
tissu
section
perform
histolog
studi
jd
help
experiment
design
data
analysi
prepar
manuscript
kss
oversaw
aspect
studi
involv
experiment
design
data
analysi
manuscript
prepar
author
read
approv
final
manuscript
